Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) hasn’t exactly had a bad year — CYCC stock was up 15.5% for the year through Friday. That’s plenty enough to celebrate considering the iShares Nasdaq Biotechnology …
Cyclacel
click to enlarge ) Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) showed buying strength all day. The 6.20 area is a critical resistance region that …
On Monday, shares of Cyclacel Pharmaceuticals (CYCC - Free Report) are skyrocketing, up over 50% after the company reported positive Phase 1 data for one of its lead drug candidates. The trial revolves around Seliciclib, …
ZACKS7mon
Cyclacel
At close on Tuesday, the biopharmaceutical company had a market capitalization of $82.65M and ANTH stock
Cyclacel
Cyclacel Pharmaceuticals updated its Phase 1 data from the DNA damage response program, and presented …
Trading of the Company’s common stock on The NASDAQ Capital Market will continue, on a split-adjusted basis, with the opening of the markets on Tuesday, May 31, 2016, under the existing trading symbol “CYCC” and …
Cyclacel Pharmaceuticals is having an incredible day in the market today, and for good reason. Early this morning, the company reported Phase 1 data surrounding one of its lead candidates, and that data was …
Traders are bullish on Cyclacel Pharmaceuticals (CYCC) as it has outperformed the S&P 500 by a wide margin of 5.42% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has …
Shares of Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) are showing high volatlity in today’s session as …